NCT05652257View on ClinicalTrials.gov

A Study of the Absorption, Metabolism, and Excretion of [14C]-Brensocatib Following a Single Oral Administration in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 13, 2021

Primary Completion Date

September 14, 2021

Study Completion Date

September 14, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]-brensocatib

Oral solution.

Trial Locations (1)

53704

USA001, Madison

All Listed Sponsors
lead

Insmed Incorporated

INDUSTRY

NCT05652257 - A Study of the Absorption, Metabolism, and Excretion of [14C]-Brensocatib Following a Single Oral Administration in Healthy Male Participants | Biotech Hunter | Biotech Hunter